Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
How does the evolution of obesity pharmacotherapy, from early appetite-suppressant drugs to modern GLP-1 receptor agonists, reflect advancements in our understanding of metabolic processes and patient safety concerns
E-mail: [email protected]
Gempharmatech Co., Ltd., Jiangsu, Nanjing, China) were given general anesthesia by intraperitoneal injection of pentobarbital (50 mg/kg body weight)
"Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease"
C., Lavandero, S., and Concha, I
US$ 25.32
US$ 28.82
US$ 22.67
US$ 21.34
US$ 26.26
US$ 23.15
US$ 22.56
US$ 26.76
US$ 23.22
US$ 24.75
